Thrilled to announce that Pacalis Therapeutics Pty Ltd was the joint winner of the Early-Stage Innovation Forum at AusBiotech 2024 in Melbourne last week. My thanks to the organising committee, session chair Sarah Meibusch, panel members and fellow participants for putting on a great event. Thanks too to our Chief Scientific Adviser Chris Langmead for collecting the award on my behalf. Wonderful to have the opportunity to pitch the efforts of Pacalis to this knowledgeable audience. AusBiotech #AusBio24
Pacalis Therapeutics Pty Ltd
Biotechnology Research
Transforming mental wellbeing through scientific innovation
About us
Pacalis Therapeutics is a privately-held biotechnology company that is based in Melbourne. It is focused on the optimization and development of next-generation medicines for key classes of mental health disorders. Pacalis takes its name from the Latin adjective for 'peaceful or pertaining to peace'. We seek to address the shadow pandemic of mental health disorders. With an estimated 1 in 8 people globally suffering from these disorders, we do not accept the status quo and believe well-executed science can strive for better outcomes. PacalisTherapeutics.com
- Website
-
www.pacalistherapeutics.com
External link for Pacalis Therapeutics Pty Ltd
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Melbourne
- Type
- Privately Held
Locations
-
Primary
Get directions
Melbourne, 3000, AU